TECTONIC THERAPEUTIC, INC. Selling, General and Administrative Expense
TECTONIC THERAPEUTIC, INC. (TECX) reported Selling, General and Administrative Expense of $9.90 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2024-11-12
- TECTONIC THERAPEUTIC, INC. selling, general and administrative expense for the quarter ending 2024-09-30 was $0.00.
- TECTONIC THERAPEUTIC, INC. selling, general and administrative expense for the quarter ending 2024-06-30 was $9.90M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month |
|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $9.90M derived: sum of 2 quarters · filed 2024-11-12 | $9.90M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $9.90M 10-Q · filed 2024-08-14 | $9.90M 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |